Berri-freez Plus
NDC Package 54162-008-04

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Berri-freez Plus is for adults & children 2 years of age and olderChildren under 2 years of age, consult a doctorCleanse and dry skinApply to affected area not more than 3 to 4 times dailyMay be used with wet or dry bandages in conjunction with ice packs . Marketed by Geritrex Llc, this product is identified by NDC 54162-008 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
54162-008-04
Package Description
113 g in 1 TUBE
Product Code
54162-008
11-Digit Billing Format
54162000804
RxNorm Crosswalk
  • RxCUI: 1729323 - camphor 0.2 % / menthol 4 % / methyl salicylate 8 % Topical Gel
  • RxCUI: 1729323 - camphor 0.002 MG/MG / menthol 0.04 MG/MG / methyl salicylate 0.08 MG/MG Topical Gel
  • RxCUI: 1729328 - Berri-Freez Plus (0.2 % / 4 % / 8 % ) Topical Gel
  • RxCUI: 1729328 - camphor 0.002 MG/MG / menthol 0.04 MG/MG / methyl salicylate 0.08 MG/MG Topical Gel [Berri-Freez Plus]
  • RxCUI: 1729328 - Berri-Freez Plus (camphor 0.2 % / menthol 4 % / methyl salicylate 8 % ) Topical Gel

Clinical Specifications

Proprietary Name
Berri-freez Plus
Dosage Form
-
Usage Information
For adults & children 2 years of age and olderChildren under 2 years of age, consult a doctorCleanse and dry skinApply to affected area not more than 3 to 4 times dailyMay be used with wet or dry bandages in conjunction with ice packs 

Regulatory & Marketing

Labeler Name
Geritrex Llc
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
07-31-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 54162-008-04 identifies a specific commercial package of 113 g in 1 tube of Berri-freez Plus, labeled by Geritrex Llc. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Geritrex Llc on July 31, 2015. The current certification is valid through December 31, 2017.

How is this Geritrex Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 54162000804. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
54162-008-04
11-Digit CMS (5-4-2)
54162-0008-04

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.